ARCHIVES

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Four New DCCP Abs Established Without New Slots, More Money

January 15, 1982

Genomic Health Presents Meta-Analyses of Oncotype DX

January 28, 2011

Public Participation Hearings Develop Gals for Reducing Cancer Mortality

February 17, 1989

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

December 5, 2014

NCAB Shaping Up, But Reverts to Nonsense When Discussing “Role Of The Board”

March 11, 1983

Niederhuber Outlines NCI Grant Funding Policies for FY08.

February 8, 2008